Chemoproteomics-Enabled Covalent Ligand Screening Reveals ALDH3A1 as a Lung Cancer Therapy Target.

MLA

Counihan, Jessica L., et al. “Chemoproteomics-Enabled Covalent Ligand Screening Reveals ALDH3A1 as a Lung Cancer Therapy Target.” ACS Chemical Biology, vol. 13, no. 8, Aug. 2018, pp. 1970–77. EBSCOhost, https://doi.org/10.1021/acschembio.8b00381.

APA

Counihan, J. L., Wiggenhorn, A. L., Anderson, K. E., & Nomura, D. K. (2018). Chemoproteomics-Enabled Covalent Ligand Screening Reveals ALDH3A1 as a Lung Cancer Therapy Target. ACS Chemical Biology, 13(8), 1970–1977. https://doi.org/10.1021/acschembio.8b00381

Chicago

Counihan, Jessica L, Amanda L Wiggenhorn, Kimberly E Anderson, and Daniel K Nomura. 2018. “Chemoproteomics-Enabled Covalent Ligand Screening Reveals ALDH3A1 as a Lung Cancer Therapy Target.” ACS Chemical Biology 13 (8): 1970–77. doi:10.1021/acschembio.8b00381.